Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04624113
Title Tazemetostat and Pembrolizumab in Patients With Pembrolizumab- or Nivolumab-Resistant, Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Washington University School of Medicine

hypopharynx cancer

oral squamous cell carcinoma

oropharynx cancer

head and neck cancer

head and neck squamous cell carcinoma

laryngeal squamous cell carcinoma


Pembrolizumab + Tazemetostat

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Washington University School of Medicine Recruiting Saint Louis Missouri 63110 United States Details
*Shaded cells indicate that there was no data available from for the field